You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vascular Endothelial Growth Factor (VEGFR) inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Macular Disease Trial in Omaha

Suspended
  • Macular Disease
    • Omaha, Nebraska
    • +1 more
    Sep 16, 2022

    Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

    Recruiting
    • Refractory Angina Pectoris
    • +2 more
    • Copenhagen, Denmark
    • +1 more
    Oct 19, 2022

    Iris Trial in Assiut (Immunohistochemistry analysis)

    Not yet recruiting
    • Iris
    • Immunohistochemistry analysis
    • Assiut, Egypt
      Hassan Lotfy
    Jul 29, 2022

    Exudative Age-related Macular Degeneration Trial (intravitreal injection)

    Completed
    • Exudative Age-related Macular Degeneration
    • intravitreal injection
    • (no location specified)
    Apr 19, 2022

    Adult Diabetic Macular Edema and Suboptimal Response to

    Not yet recruiting
    • Diabetic Macular Edema
      • (no location specified)
      Jul 31, 2023

      Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

      Recruiting
      • Retinal Vein Occlusion
      • Aflibercept Ophthalmic
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Jan 5, 2022

      Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

      Recruiting
      • Diabetic Macular Edema
      • Cataract
      • Walnut Creek, California
        Bay Area Retina Associates
      Mar 1, 2022

      Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

      Recruiting
      • Macular Edema Due to Type 2 Diabetes Mellitus
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Feb 26, 2023

      Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration(nAMD)
      • HG202
      • Shanghai, Shanghai, China
      • +1 more
      Sep 4, 2023

      Anti-VEGF in Real-world

      Recruiting
      • Neovascular Age-related Macular Edema
      • +5 more
      • Beijing, Beijing, China
        Wen-Bin Wei
      Feb 2, 2022

      Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

      Not yet recruiting
      • Adenoid Cystic Carcinoma
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Mar 14, 2023

      Effect of Plasma Rich in Growth Factors on Semen Quality

      Completed
      • Vascular Endothelial Growth Factor Overexpression
      • PRGF in candidates for sperm donors
      • Leioa, Vizcaya, Spain
      • +2 more
      Jul 29, 2022

      Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

      Completed
      • Endometriosis
      • endometriosis surgery
      • other benign condition surgeries
      • Istanbul, Bagcilar, Turkey
        Bagcilar Teaching and Research Hospital
      Mar 26, 2022

      Metastatic Colorectal Cancer, Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Recurrent Trial in Hefei

      Completed
      • Metastatic Colorectal Cancer
      • +2 more
      • Hefei, Anhui, China
        The Second Hospital of Anhui Medical University
      Oct 27, 2021

      Analgesia Methods on Vascular Endothelial Growth Factor* and

      Completed
      • Breast Cancer
      • Ankara, Turkey
        Dr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
      Oct 21, 2021

      Intravitreal Injection Site and Perceived Pain

      Recruiting
      • Pain
      • Intravitreal injection site
      • Galveston, Texas
        University of Texas Medical Branch
      Jan 19, 2023

      Following Intensive Anti-VEGF Therapy in Wet AMD

      Completed
      • Age-Related Macular Degeneration
      • Budapest, Hungary
      • +1 more
      Dec 28, 2022

      Ocular Adverse Events in Neovascular Age-related Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)

      Completed
      • Cardiac Complication
      • Vascular Diseases
      • Cardiac complication induced by VEGF/VEGFR inhibitor
      • Paris, France
        AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
      Sep 24, 2019

      Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Chemotherapy plus apatinib)

      Completed
      • Recurrent Cervical Carcinoma
      • +5 more
      • Chemotherapy plus apatinib
      • Beijing, Beijing, China
        Lei Li
      Mar 12, 2022

      Maternal Serum Vascular Endothelial Growth Factor in Pregnant

      Recruiting
      • Foetal Growth Restriction
      • obstetric Ultrasound
      • serum Vascular Endothelial Growth Factor
      • Cairo, Egypt
        Nesreen Abdel Fattah Abdullah Shehata
      Jan 30, 2021

      Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

      Not yet recruiting
      • Exudative Age Related Macular Degeneration
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Nov 28, 2022